Low grade fibromyxoid sarcoma: Problems in the diagnosis and management of a malignant tumour with bland histological appearance

Pathology

Volumn 41, Issue 2, 2009, Pages 155-160

  Wu, Xiangru ^a   Petrovic, Vida ^b   Torode, Ian P ^a   Chow, Chung Wo ^a,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b VICTORIAN CLINICAL GENETICS SERVICES   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Careful follow up; Low grade fibromyxoid sarcoma; Small biopsy problems

Indexed keywords

ARTICLE; CANCER GRADING; CANCER RECURRENCE; CASE REPORT; CHILD; CHROMOSOME ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FIBROMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW GRADE FIBROMYXOID SARCOMA; LUNG METASTASIS; NEEDLE BIOPSY; PHYSICAL EXAMINATION; QUALITY OF LIFE; SCHOOL CHILD;

EID: 61649109061     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802579276     Document Type: Article

References (22)

1. Evans HL. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol 1987; 88: 615-9.
2. Evans HL. Low-grade fibromyxoid sarcoma: a report of 12 cases. Am J Surg Pathol 1993; 17: 595-600.
3. Goodlad JR, Mentzel T, Fletcher CDM. Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity. Histoathology 1995; 26: 229-37.
4. Lane KL, Shannon RJ, Weiss SW. Hyalinising spindle cell tumour with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma. Am J Surg Pathol 1997; 21: 1481-8.
5. Berjarno PA, Padhya TA, Smith R, et al. Hyalinising spindle cell tumor with giant rosettes - a soft tissue tumor with mesenchymal and neuroendocrine features: an immunohistochemical, ultrastructural and cytogenetic analysis. Arch Pathol Lab Med 2000; 124: 1179-84.
6. Reid R, de Silva MV, Paterson L, et al. Low grade fibromyxoid sarcoma and hyalinsing spindle cell tumour with giant rosettes share a common t(7; 16)(q34; p11) translocation. Am J Surg Pathol 2003; 27: 1229-36.
7. Storlazzi CT, Mertens F, Nascimento A, et al. Fusion of the FUS and BBF2H7 genes in low grade fibromyxiod sarcoma. Hum Mol Genet 2003; 12: 2349-58.
8. Panagopoulos I, Storlazzi CT, Fletcher CDM, et al. The chimeric FUS/CREB3L2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer 2004; 40: 218-28.
9. Mertens F, Fletcher CDM, Antonescu CR, et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest 2005; 85: 408-15.
10. Matsuyama A, Hisaoka M, Shimajiri S, et al. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Am J Surg Pathol 2006; 30: 1077-84.
11. Folpe AL, Lane KL, Paull G, et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumorwith giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am J Surg Pathol 2000; 24: 1353-60.
12. Billings SD, Giblen G, Fanburg-Smith JC. Superficial low-grade fibromyxoid sarcoma (Evans tumor): a clinicopathologic analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol 2005; 29: 204-10.
13. Schaffer LG, Tommerup N. ICSN 2005: An International System for Human Cytogenetic Nomenclature. Basel: S Karger, 2005.
14. Hornick JL, Fletcher CD. Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features. Am J Surg Pathol 2005; 29: 845-58.
15. Folpe AL, Billings SD, McKenney JK, et al. Expression of claudin-1, a recently described tight junction-associated protein, distinguishes soft tissue perineurioma from potential mimics. Am J Surg Pathol 2002; 26: 1620-6.
16. Kempson RL, Fletcher CD, Evans HL, et al. Tumors of the Soft Tissues. Atlas of Tumor Pathology, Series 3, Fascicle 30. Washington, DC: Armed Forces Institute of Pathology, 2001; 52-5.
17. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005; 29: 653-9.
18. Downs-Kelly E, Goldblum JR, Patel RM, et al. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms. Am J Surg Pathol 2008; 32: 8-13.
19. Rossi S, Szuhai K, Ijszenga M, et al. EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma. Clin Cancer Res 2007; 13: 7322-8.
20. Choi HW, Shin MG, Sawyer JR, et al. Unusual type of TLS/ FUS-ERG chimeric transcript in a pediatric acute myelocytic leukaemia with 47,XX,+10,t(16;21)(p11;q22). Cancer Genet Cytogenet 2006; 167: 172-6.
21. Kanazawa T, Ogawa C, Taketani T, et al. TLS/FUS-ERG fusion gene in acute lymphoblastic leukaemia with t(16;21)(p11;q22) and monitoring of minimal residual disease. Leuk Lymphoma 2005; 46: 1833-5.
22. Ng TL, O'Sullivan MJ, Pallen CJ, et al. Ewing sarcoma with novel translocation t(2; 16) producing an in-frame fusion of FUS and FEV. J Mol Diagn 2007; 9: 459-63.